FDA approves Dornier's thermotherapy device:
This article was originally published in Clinica
The FDA has approved Dornier MedTech's microwave thermotherapy device to treat benign prostatic hyperplasia. According to the Georgia-based company, the portable and compact Urowave unit delivers 90 watts of power to the tissue, which was "more than any other product on the market". The device, which also offers fully-automated software, has a urethral therapy probe which allows 360-degree cooling.
You may also be interested in...
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.